Skip to content

Absci Corporation ABSI Return on equity

Return on equity at other companies

Schrodinger logo
SchrodingerSDGR
-45.7%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
-57.2%-14.4pp
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
-31.1%-10.7pp
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-14.7%-0.8pp
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-343.8%-1,012pp
ADMA Biologics logo
ADMA BiologicsADMA
43.3%-35.2pp

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Calculated from Absci Corporation’s reported figures.

Based on trailing twelve months.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's return on equity?
Absci Corporation (ABSI) reported return on equity of -63.9% in Q1 2026.
How has Absci Corporation's return on equity changed year-over-year?
Absci Corporation's return on equity decreased by 30.4% year-over-year, from -49% to -63.9%.
What is the long-term trend for Absci Corporation's return on equity?
Over 3 years (2022 to 2025), Absci Corporation's return on equity has grown at a 24.0% compound annual growth rate (CAGR), from -32.8% to -62.5%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.